. "Appendix B: Public Meeting Agenda, February 9, 2004." Immunization Safety Review: Vaccines and Autism. Washington, DC: The National Academies Press, 2004.
The following HTML text is provided to enhance online
readability. Many aspects of typography translate only awkwardly to HTML.
Please use the page image
as the authoritative form to ensure accuracy.
Immunization Safety Review: Vaccines and Autism
9:30–10:00 am
Association of Autistic Spectrum Disorder and MMR Vaccine: A Systematic Review of Current Epidemiological Evidence
Kumanan Wilson, M.D., M.Sc., Division of Clinical Decision Making and Health Care, Toronto General Research Institute, Canada
10:00–10:30 am
Age at First Measles-Mumps-Rubella Vaccination in Children with Autism and School-Matched Control Subjects
Frank DeStefano, M.D., Centers for Disease Control and Prevention
10:30–10:45 am
Break
10:45–11:15 am
Exposure to Thimerosal-Containing Vaccines in U.K. Children and Autism
Dr. Elizabeth Miller, Head, Immunisation Division, Public Health Laboratory Service, Communicable Disease Surveillance Centre, London
11:15–11:45 am
Vaccine Safety Datalink Study: Autism Outcome
Robert L. Davis, M.D., M.P.H., University of Washington Group Health, Cooperative Departments of Pediatrics Center for Health Studies and Epidemiology
11:45–12:15 pm
Study of the Association Between Thimerosal-Containing Vaccine and Autism in Denmark
Anders Peter Hviid, M.Sc., Department of Epidemiology Research, State Serum Institute, Copenhagen, Denmark
12:15–12:45 pm
Autism and Thimerosal-Containing Vaccines: Analysis of the Vaccine Adverse Events Reporting System (VAERS)
Mark R. Geier, M.D., Ph.D., President, The Genetic Centers of America
